ReviewLasers in medical science2025
Progress in the application of ablative fractional lasers in chronic wounds.
Review in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Plant Exosome Injection with or without Low Level Laser Therapy Promotes Skin Wound Healing: An Experimental Study.Plastic and reconstructive surgery. Global open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This literature review aims to explore the application of ablative fractional laser in chronic wound healing, focusing on its clinical efficacy and mechanisms of action. Additionally, it summarizes the various lasers and parameters utilized by the authors in their studies. A comprehensive literature search was conducted for studies published between 2008 and 2025 in the Google Scholar, Web of Science, Medline, and PubMed databases, using the keywords: Fractional, Laser, Chronic Wounds, Ulcers, Healing. A substantial body of evidence suggests that carbon dioxide (CO₂) and erbium: yttrium aluminum garnet (Er: YAG) lasers can significantly accelerate the healing of chronic wounds. However, treatment protocols vary considerably across studies, particularly in terms of treatment frequency, power output, and energy density. This lack of standardization makes it challenging to compare outcomes directly and to determine optimal treatment parameters. The majority of studies conclude that CO₂ and Er: YAG laser therapies effectively promote the repair of chronic wounds. Proposed mechanisms include precise debridement, reduction of bacterial burden, improved local perfusion, enhanced transdermal drug delivery, and activation of key signaling pathways, such as Transforming growth factor-β/smad(TGF-β/Smad). Further research is needed to establish standardized treatment protocols and identify the most effective laser parameters for clinical use.
Indexed as
Identifiers
40387947What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.